
Trending News Today: ACA Uncertainty Creates Challenges for Insurers Crafting 2018 Plans
Top news of the day from across the healthcare landscape.
The FDA recently approved 2 drugs to treat children aged 12 to 17 with hepatitis C virus (HCV). This population likely became infected with HCV by their mothers during pregnancy and are less likely to become infected through drug use. While adults, especially those insured through Medicaid, have had a notoriously hard time receiving coverage for HCV treatment, some experts say that pediatric patients may bypass those difficulties, according to
According to a new lawsuit, 2 US Army veterans are alleging that they were denied honorable discharges due to a lack of consideration of mental health conditions, including post-traumatic stress disorder (PTSD). One of the plaintiffs was battling depression and went absent-without-leave (AWOL) to attend his wedding. Upon return, he was diagnosed with depression and discharged from going AWOL,
Health insurers are facing new challenges in drafting 2018 plans due to the uncertain fate of the Affordable Care Act. While the Trump administration has made an attempt to repeal the law, the proposed American Health Care Act is still in the process of undergoing revisions, making the job of insurers—who only have a few more weeks to create new plans—more difficult. The uncertainty may cause some insurers to withdraw from the marketplaces or substantially increase premiums, according to
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.